Efficacy and safety of paliperidone palmitate 3-month formulation in schizophrenia: A randomized, double-blind, placebo-controlled study

Authors
Category Primary study
JournalEuropean Psychiatry
Year 2015
This article has no abstract
Epistemonikos ID: fd90a1fd93ae41383fbebcdcfb1a2836188519b5
First added on: Feb 07, 2025